The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma

References

• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114: 97–109.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25: 953–64.
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, et al. Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci 2013;20:1422–6.
   PubMed Web of Science ®Google Scholar
• Adeberg S, Konig L, Bostel T, Harrabi S, Welzel T, Debus J, et al. Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone. Int J Radiat Oncol Biol Phys 2014;90:886–93.
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992–1000.
   PubMed Web of Science ®Google Scholar
• van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. New Engl J Med 2001;345:1359–67.
   PubMed Web of Science ®Google Scholar
• Woodworth GF, Chaichana KL, McGirt MJ, Sciubba DM, Jallo GI, Gokaslan Z, et al. Predictors of ambulatory function after surgical resection of intramedullary spinal cord tumors. Neurosurgery 2007;61:99–105; discussion -6.
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123:309–14.
   PubMed Web of Science ®Google Scholar
• Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927;8:519–30.
   PubMedGoogle Scholar
• Jelluma N, Yang X, Stokoe D, Evan GI, Dansen TB, Haas-Kogan DA. Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res 2006;4:319–30.
   PubMed Web of Science ®Google Scholar
• Suba Z, Barabas J, Szabo G, Takacs D, Ujpal M. Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 2005;28:228.
   PubMed Web of Science ®Google Scholar
• Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001;84:417–22.
   PubMed Web of Science ®Google Scholar
• Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prevent 2002;11:385–91.
   PubMed Web of Science ®Google Scholar
• Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H. Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme. Strahlenther Onkol 2014;190: 933–8.
   PubMed Web of Science ®Google Scholar
• Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA. Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 2009;27:1082–6.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193–203.
   PubMed Web of Science ®Google Scholar
• Michaelsen SR, Christensen IJ, Grunnet K, Stockhausen MT, Broholm H, Kosteljanetz M, et al. Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: An observational study of a cohort of consecutive non-selected patients from a single institution. BMC Cancer. 2013;13:402.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008;134:703–7.
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: Connections of metabolism and cell proliferation. Ann NY Acad Sci 2011;1243:54–68.
   PubMed Web of Science ®Google Scholar
• Oudard S, Arvelo F, Miccoli L, Apiou F, Dutrillaux AM, Poisson M, et al. High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 1996;74:839–45.
   PubMed Web of Science ®Google Scholar
• Lichtor T, Dohrmann GJ. Respiratory patterns in human brain tumors. Neurosurgery 1986;19:896–9.
   PubMed Web of Science ®Google Scholar
• Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, et al. Metformin: Taking away the candy for cancer? Eur J Cancer 2010;46:2369–80.
   PubMed Web of Science ®Google Scholar
• Welch MR, Grommes C. Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients. CNS Oncol 2013;2:237–46.
   PubMedGoogle Scholar
• Suba Z, Ujpal M. [Correlations of insulin resistance and neoplasms]. Magyar Onkol 2006;50:127–35.
   PubMedGoogle Scholar
• McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, et al. Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 2008;63:286–91; discussion 91.
   PubMed Web of Science ®Google Scholar
• Guo D, Cloughesy TF, Radu CG, Mischel PS. AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas. Cell Cycle 2010;9:211–2.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhao S. Metabolic changes in cancer: Beyond the Warburg effect. Acta Biochim Biophys Sin 2013;45: 18–26.
   Google Scholar
• Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, et al. Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 2010;94: 102–9.
   PubMed Web of Science ®Google Scholar
• Yamamori T, Meike S, Nagane M, Yasui H, Inanami O. ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51. FEBS Letters 2013; 587:3348–53.
   PubMed Web of Science ®Google Scholar
• Vaupel P. Metabolic microenvironment of tumor cells: A key factor in malignant progression. Exp Oncol 2010;32:125–7.
   PubMedGoogle Scholar
• Boyd DB. Insulin and cancer. Integr Cancer Ther 2003;2: 315–29.
   PubMedGoogle Scholar
• Chinot OL, Wick W, Cloughesy T. Bevacizumab for newly diagnosed glioblastoma. New Engl J Med 2014;370:2049.
   PubMed Web of Science ®Google Scholar